Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
CAH Quote, Financials, Valuation and Earnings
Last price:
$207.61
Seasonality move
:
8.71%
Day range:
$207.26 - $209.07
52-week range:
$117.53 - $214.93
Dividend yield:
0.98%
P/E ratio:
31.34x
P/S ratio:
0.21x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
2.3M
1-year change:
74.65%
Market cap:
$49.3B
Revenue:
$222.6B
EPS (TTM):
$6.62
Analysts' Opinion
-
Consensus RatingCardinal Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $216.60, Cardinal Health, Inc. has an estimated upside of 4.45% from its current price of $207.54.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $167.00 representing 19.56% downside risk from its current price of $207.54.
Fair Value
-
According to the consensus of 14 analysts, Cardinal Health, Inc. has 4.45% upside to fair value with a price target of $216.60 per share.
CAH vs. S&P 500
-
Over the past 5 trading days, Cardinal Health, Inc. has overperformed the S&P 500 by 3.32% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cardinal Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cardinal Health, Inc. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Cardinal Health, Inc. reported revenues of $64B.
Earnings Growth
-
Cardinal Health, Inc. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Cardinal Health, Inc. reported earnings per share of $1.88.
Enterprise value:
53.9B
EV / Invested capital:
8.55x
Price / LTM sales:
0.21x
EV / EBIT:
19.33x
EV / Revenue:
0.23x
PEG ratio (5yr expected):
1.16x
EV / Free cash flow:
12.10x
Price / Operating cash flow:
11.23x
Enterprise value / EBITDA:
14.85x
Gross Profit (TTM):
$8.4B
Return On Assets:
3.23%
Net Income Margin (TTM):
0.69%
Return On Equity:
--
Return On Invested Capital:
31.66%
Operating Margin:
1.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $210B | $224.5B | $234.3B | $52.3B | $64B | |
| Gross Profit | $6.8B | $7.3B | $8.4B | $1.8B | $2.2B | |
| Operating Income | $2B | $2.2B | $2.8B | $557M | $771M | |
| EBITDA | $2.7B | $2.9B | $3.6B | $739M | $1B | |
| Diluted EPS | $0.57 | $5.22 | $6.62 | $1.70 | $1.88 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.7B | $32.7B | $34.7B | $32.9B | $38.5B | |
| Total Assets | $43B | $43.4B | $43.7B | $43.1B | $55.2B | |
| Current Liabilities | $26.5B | $31.6B | $35.1B | $34.7B | $40.3B | |
| Total Liabilities | $41.6B | $45.2B | $47.2B | $46.3B | $58B | |
| Total Equity | $1.4B | -$1.8B | -$3.5B | -$3.3B | -$2.7B | |
| Total Debt | $5.7B | $5.3B | $4.7B | $5.2B | $9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.3B | $1.6B | $5B | -$1.6B | $973M | |
| Cash From Investing | -$450M | -$1.9B | -$5.7B | -$88M | -$145M | |
| Cash From Financing | -$2.6B | -$721M | $2.4B | -$540M | -$107M | |
| Free Cash Flow | $2.8B | $1.1B | $4.5B | -$1.7B | $865M | |
CAH
Sector
Market Cap
$49.3B
$28M
Price % of 52-Week High
96.59%
51.03%
Dividend Yield
0.98%
0%
Shareholder Yield
1.51%
-1.54%
1-Year Price Total Return
75.22%
-17.48%
Beta (5-Year)
0.626
0.518
Dividend yield:
0.98%
Annualized payout:
$2.02
Payout ratio:
27.13%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$202.31
200-day SMA
Buy
Level
$160.77
Bollinger Bands (100)
Buy
Level
148.06 - 197.1
Chaikin Money Flow
Buy
Level
1.1B
20-day SMA
Buy
Level
$202.32
Relative Strength Index (RSI14)
Buy
Level
67.95
ADX Line
Buy
Level
27.91
Williams %R
Sell
Level
-4.288
50-day SMA
Buy
Level
$193.06
MACD (12, 26)
Buy
Level
2.39
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
556.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.7386)
Sell
CA Score
(Annual)
Level (-1.0313)
Buy
Beneish M-Score
(Annual)
Level (-2.3028)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.0946)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Stock Forecast FAQ
In the current month, CAH has received 10 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CAH average analyst price target in the past 3 months is $216.60.
-
Where Will Cardinal Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cardinal Health, Inc. share price will rise to $216.60 per share over the next 12 months.
-
What Do Analysts Say About Cardinal Health, Inc.?
Analysts are divided on their view about Cardinal Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardinal Health, Inc. is a Sell and believe this share price will drop from its current level to $167.00.
-
What Is Cardinal Health, Inc.'s Price Target?
The price target for Cardinal Health, Inc. over the next 1-year time period is forecast to be $216.60 according to 14 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CAH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cardinal Health, Inc. is a Buy. 10 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CAH?
You can purchase shares of Cardinal Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardinal Health, Inc. shares.
-
What Is The Cardinal Health, Inc. Share Price Today?
Cardinal Health, Inc. was last trading at $207.61 per share. This represents the most recent stock quote for Cardinal Health, Inc.. Yesterday, Cardinal Health, Inc. closed at $207.54 per share.
-
How To Buy Cardinal Health, Inc. Stock Online?
In order to purchase Cardinal Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CAH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CAH
Sector
P/E ratio
31.34x
23.89x
PEG ratio
1.16x
-0.01x
P/B ratio
--
1.82x
Price / LTM sales
0.21x
1.60x
Growth Metrics
CAH
Sector
Revenue growth
22.44%
4.62%
Earnings growth
10.88%
10.88%
Revenue (5-year growth)
7.8%
6.5%
Earnings forecast
$2.17
-$0.21
Profitability
CAH
Sector
Profitability FY 2025
$7.9B
$3.5M
Return on invested capital
31.66%
-31.77%
Return on assets
3.23%
-27.96%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Jan
29
Balance Sheet
CAH
Sector
Total cash
$4.6B
$26.3M
Short term investments
--
$25.7M
Total assets
$53.1B
$78M
Long term debt
$9B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
